SUBSCRIBE
SUBSCRIBE
News   Business

Abraxis BioScience, Inc. Appoints David O’Toole as Chief Financial Officer

May 28, 2008 | 
1 min read
LOS ANGELES--(BUSINESS WIRE)--Abraxis BioScience, Inc. (NASDAQ:ABII), an integrated, global biotechnology company, today announced that David O’Toole has been appointed Executive Vice President and Chief Financial Officer, succeeding Lisa Gopala.
People
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
LENZ cuts 75% of staff as third quarter earnings disappoint
October 29, 2026
 · 
111 min read
 · 
BioSpace Editorial Staff
Conceptual illustration of a businessman swings on a wrecking ball with Dollar symbol engraved on it
Earnings
Lilly can’t stop, won’t stop as revenue climbs 39% thanks to GLP-1 bestsellers
October 29, 2026
 · 
1 min read
 · 
Annalee Armstrong
Insights
Stability, speed and strategy: Inside Australia’s early‑stage edge
October 29, 2026
 · 
1 min read
 · 
Jennifer C. Smith-Parker
Contemporary art collage. Motivated, confident team go over light background with abstract object, red arrows. Concept of business development, teamwork, startup, finance, career.
Job Trends
Biopharma cuts at manufacturing plants expected to affect 4,000+
October 29, 2026
 · 
5 min read
 · 
Angela Gabriel